Records containing: Metastatic Malignant Neoplasm in the Central Nervous System
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-01Patient and Caregiver Priorities in Neuro-Oncology Care
-
CLINICAL_TRIALS study record update · 2026-03-30Phase I Study to Evaluate Safety, Tolerability, Pharmacokinetics and Anti-Tumor Activity of WSD0922-FU
-
CLINICAL_TRIALS study record update · 2026-02-24A Phase 1/2 Trial of CBL0137 (NSC# 825802) in Patients With Relapsed or Refractory Solid Tumors Including CNS Tumors and Lymphoma
-
CLINICAL_TRIALS study record update · 2025-08-19Phase 1 Study of E6201 Plus Dabrafenib for the Treatment of Central Nervous System (CNS) Metastases From BRAF V600-Mutated Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2025-01-08Validation of a Multi-Parametric Ultra-High Field MRI Protocol for Central Nervous System Malignancy
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2023-12-18A Pilot Study to Assess Lactate and Bicarbonate Detection Within Malignant Brain Tumors Using [1-13C]-Pyruvate DNP Magnetic Resonance Spectroscopy (MRS)
-
CLINICAL_TRIALS study record update · 2022-02-18Phase II Study of Brigatinib for Advanced Solid Cancers Harboring Genomic Alterations in ALK (Excluding Lung) and ROS1 Oncogenes